UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dual drug delivery of tamoxifen and quercetin: Regulated metabolism for anticancer treatment with nanosponges

Journal of controlled release, 2015-12, Vol.220 (Pt B), p.751-757

2015

Volltextzugriff (PDF)

One-pot polyglycidol nanogels via liposome master templates for dual drug delivery

Journal of controlled release, 2016-12, Vol.244 (Pt B), p.366-374

2016

Volltextzugriff (PDF)

Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia

Molecular psychiatry, 2007-06, Vol.12 (6), p.572-580

2007

Volltextzugriff (PDF)

Metal-organic insertion light initiated radical (MILRad) polymerization: photo-initiated radical polymerization of vinyl polar monomers with various palladium diimine catalysts

Polymer chemistry, 2019-06, Vol.1 (23), p.34-347

2019

Volltextzugriff (PDF)

(454) A randomized, double-blind, placebo-controlled, multicenter trial to assess the efficacy and safety of oxycodone/naloxone extended-release tablets (OXN) in opioid-experienced subjects with chronic low back pain

The journal of pain, 2014-04, Vol.15 (4), p.S89-S89

2014

Volltextzugriff (PDF)

(456) Effectiveness and safety of oxycodone/naloxone controlled release tablets during three 52-week open-label extension studies

The journal of pain, 2014-04, Vol.15 (4), p.S90-S90

2014

Volltextzugriff (PDF)

Butrans® (buprenorphine) Transdermal System and 7-day analgesic efficacy

The journal of pain, 2012-04, Vol.13 (4), p.S85-S85

2012

Volltextzugriff (PDF)

Responsiveness among patient-reported measures of quality of life, quality of sleep, and functional disability to pain and impact of buprenorphine transdermal system (BTDS) treatment in chronic low back pain patients

Value in health, 2013-05, Vol.16 (3), p.A122-A122

2013

Volltextzugriff (PDF)

Correlates of improvement in physical quality of life and quality of sleep among chronic low back pain patients with treatment with buprenorphine transdermal system (BTDS)

Value in health, 2013-05, Vol.16 (3), p.A122-A122

2013

Volltextzugriff (PDF)

Does depression status impact treatment effectiveness for chronic low back pain?

The journal of pain, 2013-04, Vol.14 (4), p.S82-S82

2013

Volltextzugriff (PDF)

Work and Nonvocational Domains of Functioning in Persons with Severe Mental Illness: A Longitudinal Analysis

The journal of nervous and mental disease, 1997-07, Vol.185 (7), p.419-426

1997

Volltextzugriff (PDF)

Long-term maintenance of improvements in patient-reported functioning, quality-of-life, and pain outcomes for moderate-to-severe chronic pain patients receiving continuous treatment of Butrans® (buprenorphine) Transdermal System (BTDS)

The journal of pain, 2013-04, Vol.14 (4), p.S80-S80

2013

Volltextzugriff (PDF)

PSY6 The Impact on Sleep Quality of Butrans® (Buprenorphine) Transdermal System 5 Mcg/Hour (BTDS 5) and 20 Mcg/Hour (BTDS 20) Dosages in Patients With Moderate-to-Severe Chronic Low Back Pain

Value in health, 2012-06, Vol.15 (4), p.A99-A99

2012

Volltextzugriff (PDF)

Fabry disease and chemosis

Cornea, 2009-02, Vol.28 (2), p.224-227

2009

Volltextzugriff (PDF)

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment

The Annals of thoracic surgery, 1997, Vol.63 (1), p.193-197

1997

Volltextzugriff (PDF)

Revision choanal atresia repair

International journal of pediatric otorhinolaryngology, 2003-05, Vol.67 (5), p.517-524

2003

Volltextzugriff (PDF)

Laryngeal Complications of Prolonged Intubation

Chest, 1989-10, Vol.96 (4), p.877-884

1989

Volltextzugriff (PDF)

Monocular Temporal Hemianopia With Septo-Optic Dysplasia

Journal of neuro-ophthalmology, 2006-09, Vol.26 (3), p.195-196

2006

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled Study of the Impact of the 7-Day Buprenorphine Transdermal System on Health-Related Quality of Life in Opioid-Naïve Patients With Moderate-to-Severe Chronic Low Back Pain

The journal of pain, 2013, Vol.14 (1), p.14-23

2013

Volltextzugriff (PDF)

The Impact of Buprenorphine Transdermal Delivery System on Activities of Daily Living Among Patients With Chronic Low Back Pain: An Application of the International Classification of Functioning, Disability and Health

The Clinical journal of pain, 2014-12, Vol.30 (12), p.1015-1022

2014

Volltextzugriff (PDF)

New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals

Atherosclerosis, 2004-12, Vol.177 (2), p.345-351

2004

Volltextzugriff (PDF)

PSY64 - Correlates of improvement in physical quality of life and quality of sleep among chronic low back pain patients with treatment with buprenorphine transdermal system (BTDS)

Value in health, 2013-05, Vol.16 (3), p.A122-A122

2013

Volltextzugriff (PDF)

PSY65 - Responsiveness among patient-reported measures of quality of life, quality of sleep, and functional disability to pain and impact of buprenorphine transdermal system (BTDS) treatment in chronic low back pain patients

Value in health, 2013-05, Vol.16 (3), p.A122-A122

2013

Volltextzugriff (PDF)

The colonoscopic miss rate and true one-year recurrence of colorectal neoplastic polyps

The American journal of gastroenterology, 1999-01, Vol.94 (1), p.194-199

1999

Volltextzugriff (PDF)

DETERMINANTS OF PLASMA LEVELS OF BETA-CAROTENE AND RETINOL

American journal of epidemiology, 1989-09, Vol.130 (3), p.511-521

1989

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(104)
Tagungsberichte
(1)

Sprache

Englisch
(104)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dual drug delivery of tamoxifen and quercetin: Regulated metabolism for anticancer treatment with nanosponges

One-pot polyglycidol nanogels via liposome master templates for dual drug delivery

Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia

Metal-organic insertion light initiated radical (MILRad) polymerization: photo-initiated radical polymerization of vinyl polar monomers with various palladium diimine catalysts

(454) A randomized, double-blind, placebo-controlled, multicenter trial to assess the efficacy and safety of oxycodone/naloxone extended-release tablets (OXN) in opioid-experienced subjects with chronic low back pain

(456) Effectiveness and safety of oxycodone/naloxone controlled release tablets during three 52-week open-label extension studies

Butrans® (buprenorphine) Transdermal System and 7-day analgesic efficacy

Responsiveness among patient-reported measures of quality of life, quality of sleep, and functional disability to pain and impact of buprenorphine transdermal system (BTDS) treatment in chronic low back pain patients

Correlates of improvement in physical quality of life and quality of sleep among chronic low back pain patients with treatment with buprenorphine transdermal system (BTDS)

Does depression status impact treatment effectiveness for chronic low back pain?

Work and Nonvocational Domains of Functioning in Persons with Severe Mental Illness: A Longitudinal Analysis

Long-term maintenance of improvements in patient-reported functioning, quality-of-life, and pain outcomes for moderate-to-severe chronic pain patients receiving continuous treatment of Butrans® (buprenorphine) Transdermal System (BTDS)

PSY6 The Impact on Sleep Quality of Butrans® (Buprenorphine) Transdermal System 5 Mcg/Hour (BTDS 5) and 20 Mcg/Hour (BTDS 20) Dosages in Patients With Moderate-to-Severe Chronic Low Back Pain

Fabry disease and chemosis

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment

Revision choanal atresia repair

Laryngeal Complications of Prolonged Intubation

Monocular Temporal Hemianopia With Septo-Optic Dysplasia

A Randomized, Placebo-Controlled Study of the Impact of the 7-Day Buprenorphine Transdermal System on Health-Related Quality of Life in Opioid-Naïve Patients With Moderate-to-Severe Chronic Low Back Pain

The Impact of Buprenorphine Transdermal Delivery System on Activities of Daily Living Among Patients With Chronic Low Back Pain: An Application of the International Classification of Functioning, Disability and Health

New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals

PSY64 - Correlates of improvement in physical quality of life and quality of sleep among chronic low back pain patients with treatment with buprenorphine transdermal system (BTDS)

PSY65 - Responsiveness among patient-reported measures of quality of life, quality of sleep, and functional disability to pain and impact of buprenorphine transdermal system (BTDS) treatment in chronic low back pain patients

The colonoscopic miss rate and true one-year recurrence of colorectal neoplastic polyps

DETERMINANTS OF PLASMA LEVELS OF BETA-CAROTENE AND RETINOL

Aktive Filter

Suchergebnisse filtern